Workshop: In vitro cytokine-release assays

• Date:
  Friday, 20 November 2009, All day
• Post:
  European Medicines Agency, Amsterdam, the Netherlands

To predict cytokine release syndrome: The current state-of-the-science

Documents

Agenda - Workshop: In vitro Cytokine release assays; To predict Cytokine release syndrome: The current state-of-the-science

Use of flow cytometry for investigating immunomodulatory effects of medicines: Richard Stebbings, NIBSC, England

Evaluation of the Soluble and Solid Phase Cytokine Release Assay: Thomas Kawabata, Pfizer, St. Louis, MO.

Development, validation and regulatory approval of a cytokine release test for contaminants: Peter Brà¼gger, Novartis, Switzerland.

The 24-hour whole-blood assay as potential in vitro tool to predict in vivo cytokine release following treatment with monoclonal antibodies